— King’s is blaming its herbal medicine and herbal products for a rare coronavalence that is killing more than 400 people in Kenya.
King’s is one of the world’s leading manufacturers of herbal medicines.
The company says the coronaviruses it sells are not the result of a deliberate pandemic but the result a faulty manufacturing process.
“We are very, very confident we can find and identify the cause of this,” said a company spokeswoman, Kiko Nakamura.
“We are in the process of working with the Kenyan authorities to make the products available in the country.”
King’s has been forced to shut down its entire plant in Kenya, but the company says it is working with local authorities to reopen it.
The coronaviral disease that has killed more than 300 people and sickened hundreds of thousands more has killed thousands of others and caused widespread economic losses.
The disease has also caused more than $2 billion in losses for the Kenyan government.
King says it has been cooperating with the government in the effort to bring the plant back to life.
King, which also makes herbal remedies for pain, is a global leader in the production and distribution of the herbal medicine.
The products include some of the most popular herbal remedies on the planet, including tea, water, tonics, and toothpaste.
King has been on a public relations blitz to reassure the public about the safety of the company’s herbal products.
The company is offering free samples to customers in its stores and in its online stores, and is asking customers to buy its herbal products and its supplements.
King is not issuing any additional refunds for people who have already purchased King’s products.
King said in a statement that it has reached out to the Kenyan Ministry of Health, which oversees the manufacture of health products, and to the U.S. Centers for Disease Control and Prevention, the World Health Organization and other government agencies.
The statement did not offer details about the specific steps the company is taking to bring its products back to the market.